METTL3 also induces glycolysis and enhances CRC proliferation by promoting PTTG3P, which relies on IGF2BP2 for recognition its m6A binding site (Zheng et al. 2021). This evidence concerns the gene IGF2BP2 and colorectal carcinoma.